Artivion SVP sells 11,480 shares at about $25

Rhea-AI Filing Summary

ARTIVION, INC. (AORT) reports that officer Andrew M. Green, SVP, Regulatory and Quality, sold 11,480 shares of common stock on September 10, 2026 in a sale classified as an open market or private transaction at a weighted average price of $24.97 per share. After this sale, he directly holds 40,160 shares of ARTIVION common stock. No Rule 10b5-1 trading plan is reported for this transaction, and the price reflects a weighted range between $24.84 and $25.235 per share.

Insider Trade Summary

Net Seller: 11,480 shares

Net Sell 1 txn

Insider GREEN ANDREW M

Role SVP, Regulatory and Quality

Sold 11,480 shs ($287K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	11,480	$24.97	$287K

Holdings After Transaction: Common Stock — 40,160 shares (Direct)

Footnotes (1)

1. F1. Reflects weighted average price. Range of prices were between $24.840 to $25.235. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Key Figures

Shares sold: 11,480 shares Weighted average sale price: $24.97 per share Price range: $24.84 to $25.235 per share +1 more

4 metrics

Shares sold 11,480 shares Common stock sale reported for September 10, 2026

Weighted average sale price $24.97 per share Common stock sold on September 10, 2026

Price range $24.84 to $25.235 per share Range of prices for shares included in the weighted average

Shares owned after transaction 40,160 shares Directly held by Andrew M. Green following the September 10, 2026 sale

Key Terms

weighted average price, open market or private transaction, Rule 10b5-1 plan

3 terms

weighted average price financial

"Reflects weighted average price. Range of prices were between $24.840 to $25.235."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

open market or private transaction financial

"Sale in open market or private transaction"

Rule 10b5-1 plan regulatory

"No Rule 10b5-1 trading plan is reported for this transaction"

A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did ARTIVION (AORT) report for Andrew M. Green?

ARTIVION reported that Andrew M. Green, SVP, Regulatory and Quality, sold 11,480 shares of common stock on September 10, 2026 in a transaction classified as a sale in an open market or private transaction.

At what price were the AORT shares sold in Andrew M. Green’s Form 4 filing?

The shares were sold at a weighted average price of $24.97 per share, with individual sale prices ranging between $24.84 and $25.235. The reporting person will provide full price breakdowns upon request to the Commission staff, the issuer, or a security holder.

How many AORT shares does Andrew M. Green hold after this reported sale?

Following the sale, Andrew M. Green directly holds 40,160 shares of ARTIVION common stock. This figure reflects his direct ownership position immediately after the September 10, 2026 transaction disclosed in the Form 4.

Was Andrew M. Green’s AORT stock sale made under a Rule 10b5-1 plan?

No. The Form 4 indicates that the Rule 10b5-1 checkbox is not marked, and there is no footnote stating use of a trading plan, so no Rule 10b5-1 plan is reported for this transaction.

What role does Andrew M. Green hold at ARTIVION (AORT)?

Andrew M. Green is reported as an officer of ARTIVION, serving as SVP, Regulatory and Quality. The disclosed stock sale relates to his holdings of ARTIVION common stock in that capacity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/11/2026 - 05:29 PM EDT Accepted by SEC EDGAR 09/11/2026 - 05:28 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GREEN ANDREW M

(Last) (First) (Middle)

1655 ROBERTS BLVD., NW

(Street)

KENNESAW GEORGIA 30144

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ARTIVION, INC. [ AORT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Regulatory and Quality

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/10/2026		S		11,480	D	$24.97(1)	40,160	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects weighted average price. Range of prices were between $24.840 to $25.235. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Remarks:

	/s/ Andrew M. Green	09/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)